Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [RNA-seq]

ABSTRACT: Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [RNA-seq]

PROVIDER: PRJNA723612 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14296520.fastq.gz	Fastqsanger.gz
	SRR14296521.fastq.gz	Fastqsanger.gz
	SRR14296522.fastq.gz	Fastqsanger.gz
	SRR14296523.fastq.gz	Fastqsanger.gz
	SRR14296524.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 21

Similar Datasets

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer

Project description:Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer

| PRJNA723609 | ENA

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [RNA-seq]

Project description:The Epithelial-to-Mesenchymal Transition (EMT) is a dynamic cellular program that is frequently used by cancer cells to increase migratory and invasive cell characteristics. It is a key contributor to both heterogeneity and chemo-resistance and metastasis in many solid tumors, including triple negative breast cancer. In particular, the intermediate or hybrid EMT state has increased tumor initiating and stem-like properties. Here, we have identified multiple distinct EMT states derived from the human breast cell line, SUM149PT, including three unique intermediate states, possessing distinct migratory, tumor initiating, and metastatic qualities. We have used this model to interrogate the epigenetic landscape of these distinct EMT states in a multi-omics approach, identifying and RUNX2 as relevant in regulating the intermediate state, as well as to develop a novel multiplexed staining approach to evaluate E-M heterogeneity (EMH) and overall EMT score in orthotopic tumors as well as patient tumor samples. This model reveals insights into the complex EMT spectrum of cell states, the networks that control them, and how EMT plasticity contributes to tumor heterogeneity in breast cancer.

2022-02-15 | GSE172609 | GEO

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [ATAC-seq]

2022-02-15 | GSE172608 | GEO

Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [ATAC-seq]

Project description:Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer [ATAC-seq]

| PRJNA723611 | ENA

Mechanical confinement governs phenotypic plasticity in melanoma

Project description:Mechanical confinement governs phenotypic plasticity in melanoma

| PRJNA1067145 | ENA

Mechanical confinement governs phenotypic plasticity in melanoma [HMGB2OE_RNAseq]

Project description:Mechanical confinement governs phenotypic plasticity in melanoma [HMGB2OE_RNAseq]

| PRJNA1067146 | ENA

Mechanical confinement governs phenotypic plasticity in melanoma [confined_RNAseq]

Project description:Mechanical confinement governs phenotypic plasticity in melanoma [confined_RNAseq]

| PRJNA1067147 | ENA

Mechanical confinement governs phenotypic plasticity in melanoma [HMGB2OE_ATACseq]

Project description:Mechanical confinement governs phenotypic plasticity in melanoma [HMGB2OE_ATACseq]

| PRJNA1067149 | ENA

Impact of EMT-driven plasticity on phenotypic diversity dynamics under chemotherapy [spontaneous]

Project description:Triple negative breast cancer (TNBC) is the most lethal breast cancer subgroup, as lack of targeted therapies and drug resistance reduce survival rates. Cellular plasticity enables cells to adapt non-genetically and overcome therapeutic pressure, thereby embodying a critical clinical hurdle. The epithelial-mesenchymal transition (EMT) is an example of phenotypic reprogramming linked to plasticity, drug resistance and metastasis. However, its exact impact on population diversity under therapeutic pressure is unknown. Here, we used single cell transcriptomics to investigate phenotypic diversity dynamics upon drug treatment in two human in vitro models of TNBC plasticity.

2024-12-04 | GSE263729 | GEO

Impact of EMT-driven plasticity on phenotypic diversity dynamics under chemotherapy [organoids]

2024-12-04 | GSE263728 | GEO